All
11.
Genetic polymorphisms of DNA double-strand break repair pathway genes and glioma susceptibility
Peng Zhao, Peng Zou, Lin Zhao, Wei Yan, Chunsheng Kang, Tao Jiang, Yongping You BMC Cancer 2013, 13 :234 (10 May 2013)
Abstract | Full text | PDF
| ePUB | PubMed
12.
Age dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validation
Cihan Cetinkaya, Tommy Martinsson, Johanna Sandgren, Catarina Träger, Per Kogner, Jan Dumanski, Teresita Díaz de Ståhl, Fredrik Hedborg BMC Cancer 2013, 13 :231 (9 May 2013)
Abstract | Full text | PDF
| ePUB | PubMed
13.
Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study
Alexa J Resler, Kathleen E Malone, Lisa G Johnson, Mari Malkki, Effie W Petersdorf, Barbara McKnight, Margaret M Madeleine BMC Cancer 2013, 13 :219 (1 May 2013)
Abstract | Full text | PDF
| ePUB | PubMed
14.
Quantitative threefold allele-specific PCR (QuanTAS-PCR) for highly sensitive JAK2 V617F mutant allele detection
Giada V Zapparoli, Robert N Jorissen, Chelsee A Hewitt, Michelle McBean, David A Westerman, Alexander Dobrovic BMC Cancer 2013, 13 :206 (24 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
15.
Impact of KRAS, BRAF and PI3KCA mutations in rectal carcinomas treated with neoadjuvant radiochemotherapy and surgery
Olfa Derbel, Qing Wang, Françoise Desseigne, Michel Rivoire, Pierre Meeus, Patrice Peyrat, Mattia Stella, Isabelle Martel-Lafay, Anne-Isabelle Lemaistre, Christelle de La Fouchardière BMC Cancer 2013, 13 :200 (23 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
16.
Peretinoin, an acyclic retinoid, improves the hepatic gene signature of chronic hepatitis C following curative therapy of hepatocellular carcinoma
Masao Honda, Taro Yamashita, Tatsuya Yamashita, Kuniaki Arai, Yoshio Sakai, Akito Sakai, Mikiko Nakamura, Eishiro Mizukoshi, Shuichi Kaneko BMC Cancer 2013, 13 :191 (15 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
17.
TP53 p.R337H is a conditional cancer-predisposing mutation: further evidence from a homozygous patient
Juliana Giacomazzi, Simone Selistre, Juliana Duarte, Jorge Pinto Ribeiro, Paulo JC Vieira, Gabriel de Souza Macedo, Cristina Rossi, Mauro Czepielewski, Cristina Brinkmann Oliveira Netto, Pierre Hainaut, Patricia Ashton-Prolla BMC Cancer 2013, 13 :187 (9 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
18.
Expressional alterations in functional ultra-conserved non-coding rnas in response to all -trans retinoic acid - induced differentiation in neuroblastoma cells
Karen M Watters, Kenneth Bryan, Niamh H Foley, Maria Meehan, Raymond L Stallings BMC Cancer 2013, 13 :184 (8 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
19.
Genetic variations of the A13/A14 repeat located within the EGFR 3′ untranslated region have no oncogenic effect in patients with colorectal cancer
Nasrin Sarafan-Vasseur, David Sefrioui, David Tougeron, Aude Lamy, France Blanchard, Florence Le Pessot, Frédéric Di Fiore, Pierre Michel, Stéphane Bézieau, Jean-Baptiste Latouche, Thierry Frebourg, Richard Sesboüé BMC Cancer 2013, 13 :183 (8 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
20.
A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer - a study of the OVCAD consortium
Dietmar Pils, Dan Tong, Gudrun Hager, Eva Obermayr, Stefanie Aust, Georg Heinze, Maria Kohl, Eva Schuster, Andrea Wolf, Jalid Sehouli, Ioana Braicu, Ignace Vergote, Toon Van Gorp, Sven Mahner, Nicole Concin, Paul Speiser, Robert Zeillinger BMC Cancer 2013, 13 :178 (3 April 2013)
Abstract | Full text | PDF
| ePUB | PubMed
